Market Newsdesk

SITE Centers Declares Common Stock Dividend of $0.12 for Third Quarter 2021

BEACHWOOD, Ohio–(BUSINESS WIRE)–
SITE Centers Corp. (NYSE: SITC), an owner of open-air shopping centers in suburban, high household income communities, today declared its third quarter 2021 common stock dividend of $0.12 per share. The common stock dividend is payable on October 8, 2021 to shareholders of record at the close of business on September 24, 2021.

About SITE Centers Corp.

SITE Centers is an owner and manager of open-air shopping centers located in suburban, high household income communities. The Company is a self-administered and self-managed REIT operating as a fully integrated real estate company, and is publicly traded on the New York Stock Exchange under the ticker symbol SITC. Additional information about the Company is available at www.sitecenters.com. To be included in the Company’s e-mail distributions for press releases and other investor news, please click here.

Safe Harbor

SITE Centers Corp. considers portions of the information in this press release to be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, both as amended, with respect to the Company’s expectation for future periods. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. For this purpose, any statements contained herein that are not historical fact may be deemed to be forward-looking statements. There are a number of important factors that could cause our results to differ materially from those indicated by such forward-looking statements, including, among other factors, the impact of the COVID-19 pandemic on the Company’s ability to manage its properties and finance its operations and on tenants’ ability to operate their businesses, generate sales and meet their financial obligations, including the obligation to pay ongoing and deferred rents; local conditions such as the supply of, and demand for, retail real estate space in the area; the impact of e-commerce; dependence on rental income from real property; the loss of, significant downsizing of or bankruptcy of a major tenant and the impact of any such event on rental income from other tenants and our properties; redevelopment and construction activities may not achieve a desired return on investment; our ability to buy or sell assets on commercially reasonable terms; our ability to complete acquisitions or dispositions of assets under contract; our ability to secure equity or debt financing on commercially acceptable terms or at all; impairment charges; our ability to enter into definitive agreements with regard to our financing and joint venture arrangements and our ability to satisfy conditions to the completion of these arrangements; valuation and risks relating to our joint venture and preferred equity investments; the termination of any joint venture arrangements or arrangements to manage real property; property damage, expenses related thereto and other business and economic consequences (including the potential loss of rental revenues) resulting from extreme weather conditions or natural disasters in locations where we own properties, and the ability to estimate accurately the amounts thereof; sufficiency and timing of any insurance recovery payments related to damages from extreme weather conditions or natural disasters; any change in strategy and our ability to maintain REIT status. For additional factors that could cause the results of the Company to differ materially from those indicated in the forward-looking statements, please refer to the Company’s most recent reports on Form 10-K and Form 10-Q. The impacts of the COVID-19 pandemic may also exacerbate the risks described therein, any of which could have a material effect on the Company. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210909006049/en/

Conor Fennerty, EVP and Chief Financial Officer

216-755-5500

KEYWORDS: United States North America Ohio

INDUSTRY KEYWORDS: Other Retail Commercial Building & Real Estate Construction & Property REIT Luxury Other Consumer Specialty Department Stores Retail Consumer Other Construction & Property

MEDIA:

Logo

Angel Oak Financial Strategies Income Term Trust Announces Rights Offering, Expansion of Investment Mandate, and Monthly Distribution

ATLANTA–(BUSINESS WIRE)–
Angel Oak Financial Strategies Income Term Trust (NYSE: FINS) (the “Fund”) today announced that its Board of Trustees (the “Board”) has approved the terms of the issuance of transferable rights (“Rights”) to the holders of the Fund’s common shares (“Common Shareholders”) of beneficial interest (“Common Shares”) as of September 20, 2021 (the “Record Date”). Holders of Rights will be entitled to subscribe for additional Shares (the “Offer”) at a discount to the market price of the Common Shares (subject to a sales load).

The Board and the Fund’s investment adviser, Angel Oak Capital Advisors, LLC (the “Adviser”), have determined that it is in the best interest of both the Fund and its shareholders to conduct the Offer and seek to increase the assets of the Fund available for investment to take advantage of existing and future investment opportunities that are or may become available.

In addition, the Board has also approved the expansion of the Fund’s investment mandate to seek to allow for a more diversified portfolio across the U.S. financial sector, including non-bank financial institutions such as insurance companies, asset managers, real estate investment trusts and business development companies. The expanded investment strategy could minimize risk and volatility, increase diversification, offer non-correlated income, and provide excess yield on a risk-adjusted basis.

The Adviser believes the Offer is potentially beneficial to the Fund, including in the following ways:

• Increased Diversification
  • The additional capital generated from the Offer may allow the Fund to diversify the portfolio and seek to reduce risk. Expanding the non-bank financial debt and strategic allocations could reduce the risk and volatility of the portfolio.

• Rewards Shareholders
  • The Offer provides Common Shareholders with an opportunity to buy new Common Shares below market price or realize value from the sale of Rights.

• Enhanced Liquidity
  • The Offer creates the potential for increased trading volume and liquidity of Common Shares.

• Economies of Scale
  • The Offer is expected to spread fixed operating costs across a larger asset base.

• Tax Efficiency
  • The Offer potentially mitigates sales of existing holdings that may result in the realization of capital gains, which may result in a taxable event for Common Shareholders.

“We see significant opportunities across the non-bank financials landscape today, which similarly to the banking sector has de-levered and de-risked post-Global Financial Crisis, in contrast to broader corporate credit. Interest rates remain attractive in this less-trafficked area of investment-grade fixed income and issuance trends have been positive. In addition, the sector’s response to the pandemic has generally resulted in higher capital, reserve and liquidity levels. Raising new capital to allocate into non-bank financial investments allows us to increase diversification in a tax efficient manner, while expanding the opportunity set to seek to generate compelling returns on a risk-adjusted basis,” said Cheryl Pate, Portfolio Manager for the Fund.

Terms of Rights Offering

The Fund will distribute to Common Shareholders of record as of the record date (“Record Date Shareholders”) one Right for each Common Share held on the Record Date. Record Date Shareholders will be entitled to purchase one new Common Share for every three Rights held (1 for 3); however, any Record Date Common Shareholder who owns fewer than three Common Shares as of the Record Date will be entitled to subscribe for one Common Share. Fractional Common Shares will not be issued.

The proposed subscription period is currently anticipated to commence on the Record Date and expire on October 14, 2021, unless extended by the Fund (the “Expiration Date”). The Rights are transferable and are expected to be admitted for trading on the New York Stock Exchange (the “NYSE”) under the symbol “FINS RT” during the course of the Offer. Rights may be exercised at any time during the subscription period.

The subscription price per Common Share (the “Subscription Price”) will be determined on the Expiration Date, and will be based upon a formula equal to 92.5% of the average of the last reported sales price of a Common Share of the Fund on the NYSE on the Expiration Date and each of the four (4) immediately preceding trading days (the “Formula Price”). If, however, the Formula Price is less than 86% of the Fund’s net asset value per Common Share at the close of trading on the NYSE on the Expiration Date, the Subscription Price will be 86% of the Fund’s net asset value per Common Share at the close of trading on the NYSE on that day. The estimated Subscription Price has not yet been determined.

Record Date Shareholders who exercise all of their primary subscription Rights will be eligible for an over-subscription privilege entitling Record Date Shareholders to subscribe, subject to certain limitations and allotment, for any additional Common Shares not purchased pursuant to the primary subscription.

The Fund also declared a distribution of $0.1085 per share to Common Shareholders for the month of October 2021. The record date for the distribution is October 5, 2021, and the payable date is October 29, 2021. The Fund will trade ex-distribution on October 4, 2021. This will not be payable with respect to Common Shares that are issued pursuant to the Offer after such record date.

Expansion of Investment Mandate

Under the Fund’s expanded investment mandate, the Fund’s investment objective will remain to seek current income with a secondary objective of total return. The Fund will continue to seek to achieve its investment objective by investing, under normal market circumstances, at least 80% of the value of its net assets plus the amount of any borrowings for investment purposes in securities of financial institutions. Primary changes include an expanded definition of financial institutions in which the Fund may invest, elimination of the 50% limit on non-bank issuers, and adoption of a 15% limit on investments in non-investment grade bonds and a 20% limit on investments in structured products and derivatives.

* * *

The Offer will be made pursuant to the Fund’s currently effective shelf registration statement on file with the Securities and Exchange Commission (“SEC”) and only by means of a prospectus supplement and accompanying prospectus. A final prospectus supplement and accompanying prospectus will be filed with the SEC, but has not been filed as of the date of this release. The Fund expects to distribute subscription certificates evidencing the Rights and a copy of the prospectus for the Offer to Record Date Shareholders within the United States shortly following the Record Date. To exercise their Rights, Common Shareholders who hold their Common Shares through a broker, custodian, or trust company, should contact such entity to forward their instructions to either exercise or sell their Rights on their behalf. Common Shareholders who do not hold Common Shares through a broker, custodian, or trust company, should forward their instructions to either exercise or sell their Rights by completing the subscription certificate and delivering it to the subscription agent for the Offer, together with their payment, at one of the locations indicated on the subscription certificate or in the prospectus.

ABOUT FINS

Led by Angel Oak’s experienced financial services team, FINS invests predominantly in U.S. financial sector debt as well as selective opportunities across financial sector preferred and common equity. Under normal circumstances, at least 50% of FINS’ portfolio is publicly rated investment grade or, if unrated, judged to be of investment grade quality by Angel Oak.

ABOUT ANGEL OAK CAPITAL ADVISORS, LLC

Angel Oak Capital Advisors is an investment management firm focused on providing compelling fixed-income investment solutions to its clients. Backed by a value-driven approach, Angel Oak Capital Advisors seeks to deliver attractive, risk-adjusted returns through a combination of stable current income and price appreciation. Its experienced investment team seeks the best opportunities in fixed income, with a specialization in mortgage-backed securities and other areas of structured credit.

Information regarding the Fund and Angel Oak Capital Advisors can be found at www.angeloakcapital.com.

Past performance is neither indicative nor a guarantee of future results. Investors should read the prospectus supplement and accompanying prospectus, when available, and consider the investment objective and policies, risk considerations, charges and ongoing expenses of an investment carefully before investing. For more information please contact your investment representative or Georgeson at 888.293.6908.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210909006038/en/

Media:

Trevor Davis, Gregory FCA for Angel Oak Capital Advisors

443-248-0359

[email protected]

Company Contact:

Randy Chrisman, Chief Marketing & Corporate IR Officer, Angel Oak Capital Advisors

404-953-4969

[email protected]

KEYWORDS: United States North America Georgia

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo

Calista Corporation, Doyon Limited, Gana-A ‘Yoo Limited and Alaska Communications Seek to Provide High-Speed Internet to Almost 12,000 Unserved Alaskans

FAIRBANKS, Alaska–(BUSINESS WIRE)–
Nearly 12,000 rural Alaskans in 23 communities along the Yukon and Kuskokwim Rivers would receive high-speed internet for the first time, if the National Telecommunications and Information Administration (NTIA) approves requests for tribal broadband grants.

The Alaska FiberOptic Project, a collaboration between Calista Corporation, Doyon, Limited, Gana-A ‘Yoo Limited and Alaska Communications, would connect one of the most underserved regions in the United States with a fiber-optic cable that would be the foundation for expanding broadband to communities in the region. It would offer Gigabit service in communities that today cannot access virtual meetings, online classes, telehealth, or online jobs.

The four companies recognize that reliable, affordable, high-speed internet is the foundation for education, healthcare, economic growth, and quality of life. The COVID-19 pandemic has highlighted the importance of broadband and illuminated the growing digital divide. The Alaska FiberOptic Project will bridge that divide for many Alaska Natives.

“We have met regularly, over the years, within our Region to understand the issues and explore solutions for lack of adequate broadband connectivity,” said Aaron Schutt, president and CEO of Doyon, Limited. “Fiber-optic cable will provide the most reliable, affordable and fastest internet today and for the next generation. We intend to work collaboratively with other groups so Alaska’s many broadband projects complement each other and work to serve as many people as possible.”

“Reliable, affordable, high-speed internet is a key to connecting our people to the world, preserving and advancing our culture, and offering opportunities for young people in our communities. In combination with other broadband projects in our region, the Alaska FiberOptic Project will create the foundation for many socio-economic improvements and opportunities in the region now and for decades to come,” said Andrew Guy, president and CEO of Calista Corporation.

“Gana-A Yoo, Limited is excited to join its partners in making the Alaska FiberOptic Project a reality by creating a fiber backbone that will positively transform our region,” said Dena Sommer-Pedebone, CEO of Gana-A ‘Yoo, Limited.

“We are grateful to Doyon, Calista and Gana-A ‘Yoo for their vision and dedication to serving their communities. We look forward to partnering with them on this project and expanding reliable, high-speed, affordable internet access in Alaska,” said Bill Bishop, president and CEO of Alaska Communications.

The proposed Alaska FiberOptic Project would create a fiber optic network that starts at Fort Yukon, ends in Napakiak and connects to Alaska Communications core network in Fairbanks. The Alaska FiberOptic Project would also deploy fiber-to-the-home in each of the 23 communities served on the route.

Grant applications were submitted to the NTIA Tribal Broadband Connectivity Program Sept. 1. NTIA expects to award grants by the end of 2021. If awarded, the project would be complete in 2024.

Calista Corporation

Calista Corporation has over 33,700 Shareholders and is the parent company of more than 30 subsidiaries in the following industries: defense contracting, construction, real estate, environmental services, natural resource development, marine transportation, oilfield services, and heavy equipment sales, service and rentals. Since 1994, Calista has provided more than $5.5 million in scholarships to its Shareholders and Descendants. Since inception, Calista has declared more than $85.9 million in dividends and distributions, and $8.2 million in Elders’ Benefit Program distributions to Shareholders. Calista can be found on Facebook, Twitter and Instagram.

Doyon, Limited

Headquartered in Fairbanks, Doyon, Limited has more than 20,100 shareholders and was established under the 1971 Alaska Native Claims Settlement Act. Doyon has subsidiaries in oilfield services, government contracting, and tourism, is also the largest private landowner in Alaska and one of the largest in North America. Its mission is to continually enhance its position as a financially strong Native corporation in order to promote the economic and social well-being of its shareholders and future shareholders, to strengthen its Native way of life, and to protect and enhance its land and resources. For more information, visit www.doyon.com.

Gana-A ‘Yoo, Limited

Gana-A ‘Yoo, Limited is the Alaska Native Village Corporation for the communities of Galena, Koyukuk, Nulato, and Kaltag. It has subsidiaries in camp and facility services, professional services, and construction management. Its mission is to provide service for customers across the globe with respect for the environment and traditional values. It envisions a future where Gana-A ‘Yoo’s success provides stability and opportunity for shareholders to be successful on their own terms. For more information, visit www.ganaayoo.com.

Alaska Communications

Alaska Communications, an affiliate of ATN International, Inc. (NASDAQ: ATNI), is the leading provider of advanced broadband and managed IT services for businesses and consumers in Alaska. The company operates a highly reliable, advanced statewide data network with the latest technology and the most diverse undersea fiber optic system connecting Alaska to the contiguous U.S. For more information, visit www.AlaskaCommunications.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210909006021/en/

Thom Leonard, Calista Corporation

907-275-2863, [email protected]

Cheyenna Kuplack, Doyon Limited

907-459-2097, [email protected]

Dena Sommer-Pedebone, Gana-A ‘Yoo Limited

907-771-6531

Heather Cavanaugh, Alaska Communications

907-564-7722

KEYWORDS: Alaska United States North America

INDUSTRY KEYWORDS: Technology VoIP Other Technology Telecommunications Mobile/Wireless Networks Internet

MEDIA:

Posted on September 9, 2021 4:08 pm

Atlassian Appoints Michelle Zatlyn, Cloudflare Co-Founder, President, and COO, to Board of Directors

Atlassian Appoints Michelle Zatlyn, Cloudflare Co-Founder, President, and COO, to Board of Directors

TEAM, Anywhere/SAN FRANCISCO–(BUSINESS WIRE)–
Atlassian Corporation Plc (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, today announced it has appointed Michelle Zatlyn to its board of directors. Michelle is the co-Founder, COO, and President of Cloudflare, Inc. (NYSE: NET), the security, performance, and reliability company helping to build a better Internet.

“When Michelle and her fellow co-founders started Cloudflare 11 years ago, they began with the mission to help build a better Internet,” said Mike Cannon-Brookes, Atlassian’s co-founder and co-CEO. “That core ethos has been central to Cloudflare’s incredible growth to a public company with 16 global offices and over 2,000 employees. We are thrilled that she will bring her experience and perspective as a proven operator at such a mission-driven and disruptive company like Cloudflare to the Atlassian board.”

Cloudflare is a global cloud services provider that delivers a broad range of services to businesses of all sizes and in all geographies—making them more secure, enhancing the performance of their business-critical applications, and eliminating the cost and complexity of managing individual network hardware. Michelle has led Cloudflare since its inception, overseeing operations as the company transformed from a startup to a leading Internet security and infrastructure company that made its debut on the New York Stock Exchange in September 2019. Today Cloudflare blocks an average of 87 billion cyber threats each day for its customers, which includes approximately 19% of the Fortune 1,000.

Prior to co-founding Cloudflare, Michelle held positions at Google and Toshiba. Michelle currently sits on the World Economic Forum Young Global Leaders Foundation Board, and previously served on The NextGen Advisory Board for the Computer History Museum, as well as The Open Internet Advisory Committee Board for the Federal Communications Commission.

Michelle has earned many industry recognitions including being named to Fortune’s 40 Under 40 list and was part of Marie Claire’s 7th Annual New Guard, focused on women in all sectors who are known for their leadership and vision. Michelle was also awarded the “Icon of Canadian Entrepreneurship” (ICE) by C100, for her impact on the world of technology and on the Canadian entrepreneurial community.

She holds a B. Sc. degree, with distinction, from McGill University, and an MBA from Harvard Business School, where she was awarded the Dubilier Prize for Entrepreneurship.

About Atlassian

Atlassian unleashes the potential of every team. Our team collaboration and productivity software helps teams organize, discuss, and complete shared work. Teams at more than 200,000 customers, across large and small organizations – including Bank of America, Redfin, NASA, Verizon, and Dropbox – use Atlassian’s project tracking, content creation and sharing, and service management products to work better together and deliver quality results on time. Learn more about our products, including Jira Software, Confluence, Jira Service Management, Trello, Bitbucket, and Jira Align at https://atlassian.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210909006036/en/

Media Contact

Jake Standish

[email protected]

Investor Relations Contact

Martin Lam

[email protected]

KEYWORDS: Australia/Oceania Australia United States North America California

INDUSTRY KEYWORDS: Internet Security Data Management Technology Software

MEDIA:

Logo

Ameresco to Participate at Upcoming September Conferences

FRAMINGHAM, Mass.–(BUSINESS WIRE)–Ameresco, Inc. (NYSE:AMRC), a leading cleantech integrator specializing in energy efficiency and renewable energy, today announced that members of its management team will attend the following investor conferences:

• On September 10, 2021, Ameresco’s Executive Vice President, Distributed Energy Systems, Michael Bakas, will participate in a panel at the Barclays Energy Conference at 8:35am ET.
• On September 15, 2021, Ameresco’s Senior Vice President and Chief Financial Officer, Doran Hole, and Executive Vice President, Distributed Energy Systems, Michael Bakas, will participate in the Tudor, Pickering, Holt & Co. 2021 Spraberry to Mayberry: Natural Gas Virtual Conference. The company presentation will start at 10:30am ET. Management will also host virtual investor meetings throughout the day.
• On September 28, 2021, Ameresco’s Executive Vice President and General Manager, Federal Solutions, Nicole Bulgarino, will participate in the Oppenheimer’s ESG Summit. The panel will take place at 12:20pm ET. Senior Vice President and Chief Financial Officer, Doran Hole, will also host virtual investor meetings throughout the day.

About Ameresco, Inc.

Founded in 2000, Ameresco, Inc. (NYSE:AMRC) is a leading cleantech integrator and renewable energy asset developer, owner and operator. Our comprehensive portfolio includes energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions delivered to clients throughout North America and the United Kingdom. Ameresco’s sustainability services in support of clients’ pursuit of Net Zero include upgrades to a facility’s energy infrastructure and the development, construction, and operation of distributed energy resources. Ameresco has successfully completed energy saving, environmentally responsible projects with Federal, state and local governments, healthcare and educational institutions, housing authorities, and commercial and industrial customers. With its corporate headquarters in Framingham, MA, Ameresco has more than 1,000 employees providing local expertise in the United States, Canada, and the United Kingdom. For more information, visit www.ameresco.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210909006035/en/

Media:

Ameresco: Leila Dillon, 508.661.2264, [email protected]

Investor Relations: Eric Prouty, AdvisIRy Partners, 212.750.5800, [email protected]

Lynn Morgen, AdvisIRy Partners, 212.750.5800, [email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Other Energy Utilities Oil/Gas Environment Alternative Energy Energy Technology Other Technology

MEDIA:

Logo

Helen of Troy Limited Announces New $500 Million Share Repurchase Authorization

EL PASO, Texas–(BUSINESS WIRE)–Helen of Troy Limited (NASDAQ: HELE), designer, developer and worldwide marketer of consumer brand-name housewares, health and home, and beauty products, today announced that its Board of Directors has authorized the repurchase of $500 million of its outstanding common shares (“common stock” or “shares”) in keeping with its stated intention to opportunistically return to shareholders capital not otherwise deployed for core business growth or strategic acquisitions. The authorization was approved as part of the Board’s regular process of reviewing the Company’s capital allocation and existing authorization. It is effective August 25, 2021, for a period of three years, and replaces Helen of Troy’s existing repurchase authorization, of which approximately $79.5 million remained at the time the new authorization was approved.

Helen of Troy may purchase shares on a discretionary basis from time to time through open market purchases, privately negotiated transactions or other means, including through Rule 10b5-1 trading plans. The timing and amount of any transactions will be subject to the discretion of Helen of Troy and may be based upon market conditions as well as other opportunities that Helen of Troy may have for the use or investment of its capital. The repurchase program does not require the purchase of any minimum number of shares and may be implemented, modified, suspended or discontinued in whole or in part at any time without further notice.

In total, the $500 million share repurchase authorization represents approximately 9% of the Company’s outstanding common stock, based upon the Company’s closing price on August 25, 2021. As of August 25, 2021, Helen of Troy had approximately 24.1 million shares outstanding.

Julien R. Mininberg, Chief Executive Officer, stated: “A key element of our success in delivering significant long-term value creation for our shareholders has been our balanced capital allocation strategy. We believe the cash flow generation of our business, coupled with our strong financial position, will allow us to continue to reinvest in our value creation flywheel, while simultaneously making strategic acquisitions and opportunistically returning capital to shareholders. Today’s share repurchase authorization reaffirms the confidence from Helen of Troy’s management and Board in our long-term growth outlook, as well as our financial strength, as we continue to execute Phase II of our Transformation Plan.”

About Helen of Troy Limited

Helen of Troy Limited (NASDAQ: HELE) is a leading global consumer products company offering creative solutions for its customers through a diversified portfolio of well-recognized and widely-trusted brands, including OXO, Hydro Flask, Vicks, Braun, Honeywell, PUR, Hot Tools and Drybar. We sometimes refer to these brands as our Leadership Brands. All trademarks herein belong to Helen of Troy Limited (or its subsidiaries) and/or are used under license from their respective licensors.

For more information about Helen of Troy, please visit http://investor.helenoftroy.com

Forward Looking Statements

Certain written and oral statements made by the Company and subsidiaries of the Company may constitute “forward-looking statements” as defined under the Private Securities Litigation Reform Act of 1995. This includes statements made in this press release. Generally, the words “anticipates”, “believes”, “expects”, “plans”, “may”, “will”, “would”, “should”, “seeks”, “estimates”, “project”, “predict”, “potential”, “currently”, “continue”, “intends”, “outlook”, and other similar words identify forward-looking statements. All statements that address operating results, events or developments that the Company expects or anticipates will occur in the future, including statements related to sales, earnings per share results, and statements expressing general expectations about future operating results, are forward-looking statements and are based upon its current expectations and various assumptions. The Company believes there is a reasonable basis for these expectations and assumptions, but there can be no assurance that the Company will realize these expectations or that these assumptions will prove correct. Forward-looking statements are subject to risks that could cause them to differ materially from actual results. Accordingly, the Company cautions readers not to place undue reliance on forward-looking statements. The forward-looking statements contained in this press release should be read in conjunction with, and are subject to and qualified by, the risks described in the Company’s Form 10-Q for the three months ended May 31, 2021, and in the Company’s other filings with the SEC. Investors are urged to refer to the risk factors referred to above for a description of these risks. Such risks include, among others, the Company’s ability to successfully manage the demand, supply, and operational challenges associated with the actual or perceived effects of COVID-19 and any similar future public health crisis, pandemic or epidemic, the Company’s ability to deliver products to its customers in a timely manner and according to their fulfillment standards, actions taken by large customers that may adversely affect the Company’s gross profit and operating results, the Company’s dependence on the strength of retail economies and vulnerabilities to any prolonged economic downturn, including from the effects of COVID-19, the Company’s dependence on sales to several large customers and the risks associated with any loss of, or substantial decline in, sales to top customers, expectations regarding recent acquisitions and any future acquisitions or divestitures, including the Company’s ability to realize related synergies along with its ability to effectively integrate acquired businesses or disaggregate divested businesses, the Company’s reliance on its Chief Executive Officer and a limited number of other key senior officers to operate its business, obsolescence or interruptions in the operation of the Company’s central global Enterprise Resource Planning systems and other peripheral information systems, occurrence of cyber incidents or failure by the Company or its third-party service providers to maintain cybersecurity and the integrity of confidential internal or customer data, the Company’s dependence on third-party manufacturers, most of which are located in the Asia Pacific market, and any inability to obtain products from such manufacturers, risks associated with weather conditions, the duration and severity of the cold and flu season and other related factors, the geographic concentration and peak season capacity of certain U.S. distribution facilities which increase its risk to disruptions that could affect the Company’s ability to deliver products in a timely manner, risks associated with the use of licensed trademarks from or to third parties, the Company’s ability to develop and introduce a continuing stream of innovative new products to meet changing consumer preferences, the risks associated with trade barriers, exchange controls, expropriations, and other risks associated with domestic and foreign operations, the risks associated with significant changes in or the Company’s compliance with regulations, interpretations or product certification requirements, the risks associated with the Company’s discussions with the EPA on the development and implementation of compliance plans related to certain of its products within the Health & Home segment, the risks associated with global legal developments regarding privacy and data security that could result in changes to its business practices, penalties, increased cost of operations, or otherwise harm the business, the risks associated with accounting for tax positions and the resolution of tax disputes, the risks of potential changes in laws and regulations, including environmental, health and safety and tax laws, and the costs and complexities of compliance with such laws, the Company’s ability to continue to avoid classification as a Controlled Foreign Corporation, the risks associated with legislation enacted in Bermuda and Barbados in response to the European Union’s review of harmful tax competition, the risks of significant tariffs or other restrictions being placed on imports from China or Mexico or any retaliatory trade measures taken by China or Mexico, the risks associated with product recalls, product liability and other claims against the Company, and associated financial risks including but not limited to, significant impairment of the Company’s goodwill, indefinite-lived and definite-lived intangible assets or other long-lived assets, risks associated with foreign currency exchange rate fluctuations, increased costs of raw materials, energy and transportation, projections of product demand, sales and net income, which are highly subjective in nature, and from which future sales and net income could vary in a material amount, the risks to the Company’s liquidity or cost of capital which may be materially adversely affected by constraints or changes in the capital and credit markets and limitations under its financing arrangements. The Company undertakes no obligation to publicly update or revise any forward-looking statements as a result of new information, future events or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210909006008/en/

Investor Contact:

Helen of Troy Limited

Anne Rakunas, Director, External Communications

(915) 225-4841

ICR, Inc.

Allison Malkin, Partner

(203) 682-8200

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Home Goods Online Retail Other Retail Cosmetics Retail

MEDIA:

Posted on September 9, 2021 4:08 pm

Rezolute Announces Initiation of Dosing in the Second Cohort of its Phase 2b Trial of RZ358 for Congenital Hyperinsulinism

Tracking to Announce Top line data in Q1 2022

REDWOOD CITY, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases associated with chronic glucose imbalance, today announced that it has begun dosing patients in the second cohort of its Phase 2b clinical trial of RZ358 (RIZE). RZ358 is a monoclonal antibody targeting the treatment of hypoglycemia caused by excessive insulin levels and is currently in clinical development for congenital hyperinsulinism (HI), a rare pediatric endocrine disorder.

Rezolute reported that a dose escalation review committee, comprised of HI expert investigators, voted to approve dose escalation and initiation of cohort 2 (6 mg/kg), based on their interim review of safety data from Cohort 1 (3 mg/kg). Following completion of the second cohort, the company plans to initiate a third and likely final cohort at 9 mg/kg.

“We are making great strides with the RIZE study and based on our recent clinical trial activity, we are tracking toward the original timeline we laid out prior to the COVID-19 pandemic. In that regard, we are expecting to substantially complete enrollment by the end of 2021 and have top-line data in Q1 of 2022,” said Brian Roberts, MD, Senior Vice President and Head of Clinical Development at Rezolute. “We will continue to monitor the evolution of the pandemic, including the impact of the Delta variant, which could alter our ability to screen and enroll patients in a timely fashion.”

Rezolute also announced the addition of Adrian Vella, MD, Professor of Medicine in the Endocrinology Division at the Mayo Clinic College of Medicine, to the Company’s Scientific Advisory Board. Dr. Vella is a leading expert in hypoglycemic disorders and will provide guidance on the development of RZ358.

Dr. Roberts noted, “We are pleased to welcome Dr. Vella to our Scientific Advisory Board. Given his background and knowledge of RZ358, he will be extremely valuable to Rezolute as we advance the development of RZ358 for HI and evaluate the possibility of expanding into other related and applicable indications.”

Dr. Vella is a Professor of Medicine in the Mayo Clinic College of Medicine and has published over 160 peer reviewed articles related to endocrinology, metabolic disorders, and diabetes. He is regularly the lead author or editor on evidence-based reviews of hyperinsulinism and hypoglycemia.

About RIZE (RZ358-606)

The open-label, repeat-dose Phase 2b study is designed to assess the safety and tolerability of intravenously administered RZ358 in patients with congenital hyperinsulinism inadequately controlled on existing therapies. The Company intends to enroll up to four sequential dosing cohorts, each with up to six to eight patients, starting at a dose of 3 mg/kg and increasing to as high as 9 mg/kg in the final cohort, as needed and tolerated. RZ358 will be administered bi-weekly for a total treatment duration of 8 weeks. The study is being conducted at leading HI centers by Rezolute and its global study partners.

About RZ358

RZ358 is an intravenously administered human monoclonal antibody that binds to a unique site (allosteric) on the insulin receptor throughout the body, such as in the liver, fat, and muscle. The antibody modifies insulin’s binding and signaling to maintain glucose levels in a normal range which counteracts the effects of elevated insulin in the body. Therefore, the company believes that RZ358 is ideally suited as a potential therapy for conditions characterized by excessive insulin levels, and it is being developed to treat the hyperinsulinism and low blood sugar characteristic of diseases such as congenital HI. As RZ358 acts downstream from the beta cells, it has the potential to be universally effective at treating congenital HI caused by any of the underlying genetic defects.

RZ358 received Orphan Drug Designation in the United States and European Union as well as Pediatric Rare Disease Designation in the US. Rezolute is currently evaluating RZ358 in the RIZE trial, a Phase 2b clinical trial in patients with congenital hyperinsulinism.

About Rezolute, Inc.

Rezolute is developing transformative therapies for metabolic diseases related to chronic glucose imbalance. The Company’s lead clinical asset, RZ358, is in Phase 2b development for treatment of congenital hyperinsulinism (HI), a rare pediatric endocrine disorder. The Company is also developing RZ402, an orally available plasma kallikrein inhibitor, for the treatment of diabetic macular edema. For more information, visit www.rezolutebio.com or follow us on Twitter.

Forward-Looking Statements

This release, like many written and oral communications presented by Rezolute, Inc. and our authorized officers, may contain certain forward-looking statements regarding our prospective performance and strategies within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and are including this statement for purposes of said safe harbor provisions. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations of the Company, are generally identified by use of words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “project,” “seek,” “strive,” “try,” or future or conditional verbs such as “could,” “may,” “should,” “will,” “would,” or similar expressions. Our ability to predict results or the actual effects of our plans or strategies is inherently uncertain. Accordingly, actual results may differ materially from anticipated results. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Except as required by applicable law or regulation, Rezolute undertakes no obligation to update these forward-looking statements to reflect events or circumstances that occur after the date on which such statements were made.

Media and Investor Contact

Argot Partners
[email protected]
212-600-1902